Back to Journals » Lung Cancer: Targets and Therapy » Volume 1 » Default

Review

Standing the test of time in Europe? Gefitinib in the treatment of non-small-cell lung cancer

       
Total article views   HTML views PDF downloads Totals
6,621 Dovepress* 6,621+ 2,468 9,089
Totals 6,621 2,468 9,089
*Since 13 May 2010
+Since July 2016

View citations on Google Scholar